NASDAQ:PETS - Petmed Express Stock Price, News & Analysis

$17.34
-0.33 (-1.87 %)
(As of 09/19/2019 01:21 PM ET)
Today's Range
$17.22
Now: $17.34
$17.55
50-Day Range
$15.41
MA: $16.44
$18.47
52-Week Range
$15.00
Now: $17.34
$37.52
Volume12,524 shs
Average Volume592,484 shs
Market Capitalization$349.75 million
P/E Ratio12.26
Dividend Yield5.95%
Beta0.56
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$283.42 million
Cash Flow$1.8466 per share
Book Value$6.51 per share

Profitability

Net Income$37.74 million

Miscellaneous

Employees187
Market Cap$349.75 million
Next Earnings Date10/28/2019 (Estimated)
OptionableOptionable

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.


Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, July 22nd. Stockholders of record on Friday, August 2nd will be paid a dividend of $0.27 per share on Friday, August 9th. This represents a $1.08 annualized dividend and a dividend yield of 6.21%. The ex-dividend date of this dividend is Thursday, August 1st. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, July, 22nd. The company reported $0.26 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.42 by $0.16. The business had revenue of $79.99 million for the quarter, compared to analyst estimates of $85.83 million. Petmed Express had a net margin of 11.05% and a return on equity of 23.42%. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.62 earnings per share. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, October 28th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

1 analysts have issued 12-month price targets for Petmed Express' stock. Their forecasts range from $15.00 to $15.00. On average, they anticipate Petmed Express' share price to reach $15.00 in the next twelve months. This suggests that the stock has a possible downside of 13.7%. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Media coverage about PETS stock has been trending negative this week, according to InfoTrie. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Petmed Express earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Petmed Express.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), Alibaba Group (BABA), NVIDIA (NVDA), AT&T (T), Micron Technology (MU), Netflix (NFLX), Ford Motor (F), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Cisco Systems (CSCO).

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.27%), Renaissance Technologies LLC (9.49%), Vanguard Group Inc. (6.98%), Morgan Stanley (4.17%), Man Group plc (2.43%) and Bank of New York Mellon Corp (2.26%). Company insiders that own Petmed Express stock include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Russell Investments Group Ltd., Morgan Stanley, JPMorgan Chase & Co., Uniplan Investment Counsel Inc., Invesco Ltd., SG Americas Securities LLC and Pinebridge Investments L.P.. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Man Group plc, Vanguard Group Inc., Inlet Private Wealth LLC, Rothschild Investment Corp IL, Balter Liquid Alternatives LLC, Scout Investments Inc. and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $17.39.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $350.76 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe.View Additional Information About Petmed Express.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com/.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  166 (Thanks for Voting!)
Underperform Votes:  403 (Thanks for Voting!)
Total Votes:  569
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel